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Abstract
Although physical function decline is common with aging, the burden of this impairment
remains underestimated in patients living with HIV (PLHIV), particularly in the older people
receiving antiretroviral treatment (ART) and living in sub-Saharan Africa (SSA). PLHIV aged
�50 years old and on ART since�6 months were included (N = 333) from three clinics (two
in Côte d’Ivoire, one in Senegal) participating in the International epidemiological Databases
to Evaluate AIDS (IeDEA) West Africa collaboration. Physical function was measured using
the Short Physical Performance Battery (SPPB), the unipodal balance test and self-reported
questionnaires. Grip strength was also assessed. Logistic regression was used to identify
the factors associated with SPPB performance specifically. Median age was 57 (54–61)
years, 57.7% were female and 82.7% had an undetectable viral load. The mean SPPB score
was 10.2 ±1.8. Almost 30% had low SPPB performance with the 5-sit-to-stand test being the
most altered subtest (64%). PLHIV with low SPPB performance also had significantly low per-
formance on the unipodal balance test (54.2%, p = 0.001) and low mean grip strength (but
only in men (p = 0.005)). They also showed some difficulties in daily life activities (climbing
stairs, walking one block, both p<0.0001). Age�60 years (adjusted OR (aOR) = 3.4; CI95% =
1.9–5.9,), being a female (aOR = 2.1; CI95% = 1.1–4.1), having an abdominal obesity (aOR =
2.1; CI95% = 1.2–4.0), a longer duration of HIV infection (aOR = 2.9; CI95% = 1.5–5.7), old
Nucleoside reverse transcriptase inhibitors (NRTIs) (i.e., AZT: zidovudine, ddI: didanosine,
DDC: zalcitabine, D4T: stavudine) in current ART (aOR = 2.0 CI95% = 1.1–3.7) were associ-
ated with low SPPB performance. As in western countries, physical function limitation is now
part of the burden of HIV disease complications of older PLHIV living in West Africa, putting
this population at risk for disability. How to screen those impairments and integrate their man-
agement in the standards of care should be investigated, and specific research on developing
adapted daily physical activity program might be conducted.
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Introduction
According to UNAIDS, 6.7 million people aged 50 and older were living with HIV worldwide
in 2017, a phenomenon that increased steadily since 1995 [1]. Sub-Saharan Africa (SSA) repre-
sents the region with the largest number of older people living with HIV (PLHIV) (4.1 million)
[1]. With massive and rapid access to antiretroviral therapy (ART), the overall improvement
in HIV medical care services, and the dramatic change in the demographics of the HIV-
infected population, HIV infection can now be considered as a chronic disease worldwide.
Older patients receiving ART are thus an increasing population group and have an increased
risk of developing age-associated non-communicable comorbidities [2,3].
With aging, alteration of physical function (i.e. functional limitation and disability) are
more common. Independence and social life are clearly related to physical function in older
adults [4]. A functional limitation is a strong predictor of disability, hospitalization, nursing
home admission, and mortality in aging [5,6]. In the context of HIV infection, this problem
has long been neglected although up to 30% of PLHIV in Canada, for instance, have com-
plaints about their physical function [7]. Recent US data showed that PLHIV are affected by
those impairments even at middle age [8]. In France, it has been reported that one of two mid-
dle-aged PLHIV had poor limb muscle performance [9], that the performance deteriorated
over time and that was associated with subsequent falls [10]. In Cote d’Ivoire, one study
reported a higher prevalence of physical function limitation (34%) in middle-aged PLHIV,
with older age and higher BMI being associated with low performance [11].
As those impairments emerge as an important public health issue, there is a risk of a signifi-
cant burden on the healthcare systems and human resources, especially in SSA. Few data are
available in SSA, particularly in PLHIV aged 50 years and above. The aim of our study was to
describe the prevalence and identify factors associated with physical function impairment in
PLHIV aged 50 years and above living in West Africa.
Methods
Study population
This study is a part of an ancillary project within the West Africa network of the International
epidemiological Databases to Evaluate AIDS (IeDEA) of the US National Institutes of Health
(https://www.iedea.org/regions/west-africa/) [12]. This cross-sectional analysis is part of a
2-year longitudinal study evaluating different aspects of aging with HIV (cognition, physical
function, depression and frailty) with a follow-up still ongoing. By convenience, the study was
conducted in three urban clinics with a large case load of PLHIV in two different countries:
the infectious and tropical disease department of the Treichville University Hospital, the refer-
ral public clinic (CePReF) in Yopougon Attié Hospital (Abidjan, Côte d’Ivoire), and the infec-
tious and tropical disease department of the Fann University Hospital (Dakar, Senegal). The
inclusion period of the study was between February 2016 to November 2017.
Patients were eligible if they were adults living with HIV-1, 50 years old or older, and on
ART for at least 6 months. We excluded patients having history of cerebral opportunistic infec-
tion, neurological pathology (history of stroke, Parkinson disease), current disabling opportu-
nistic infection, meningitis, sensitivo-motor paralysis, psychiatric illness (including
psychotropic treatment), cancer under treatment or respiratory or cardiac insufficiency.
The national ethics committee of each participating country approved the protocol (Sene-
gal: Conseil National d’Ethique de la Recherche en Santé (CNERS), protocol SEN15/74; Côte
d’Ivoire: Comité National de l’Ethique et de la Recherche, protocol n˚009/IMSLS/CNER-k).
All the patients gave their written consent before being included in the study.
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Socio-demographic and medical data
Patients’ characteristics including information on socio-demographics, anthropometry, medi-
cal history, HIV clinical data, and also substance use (tobacco, drugs, and alcohol with the
AUDIT-C (a score�3 for women or�4 for men was considered as hazardous drinking) have
been collected through basic questions and medical examination.
Professional activity was defined in two categories: employed and unemployed. The Body
Mass Index (BMI) was calculated by dividing the weight (in kilograms) by the height (in
meters squared) and divided into three categories: overweight/obesity when BMI�25 kg/m2,
normal when 18� BMI <25 and low when <18 kg/m2. Abdominal obesity was defined by an
abdominal circumference�80 cm in women and�94 in men [13].
Concerning medical data, patients were asked if they have ever been diagnosed with any
chronic diseases (hypertension, diabetes, hyperlipidemia, migraine, arthrosis, tuberculosis,
etc.). The initial clinical stage using Centers for Disease Control and Prevention (CDC) defini-
tion was used (A, B, or C) [14]. Exposure to zidovudine (AZT), didanosine (ddI), stavudine
(D4T), zalcitabine (DDC) in the initial and the current ART treatment was studied through a
categorical variable (yes/no). Adherence to ART was defined as the percentage of tablets the
patient declared to have taken over seven days (in comparison to the prescribed total number
of tablets over this period).
Physical function limitation
Physical function limitation was evaluated with different tests of physical performance, and by
self-reported measures. These tests were conducted by trained staff following standard proce-
dures. Each time was recorded with a digital stopwatch.
Physical performance
■ The Short Physical Performance Battery (SPPB) [15] assesses low extremity function
using three timed components in the following order: balance, gait speed, and low limb
strength (5 times sit-to-stand test - 5STS). A score between 0 to 4 was attributed to each sub-
test, depending on the performance as defined in the Guralnik et al. standard procedures
[15]. The sum of the three components comprised the final SPPB score with a possible range
from 0 to 12 (12 indicating the highest degree of low extremity functioning). For physical
limitation, as defined by Guralnik et al [15], poor physical performance was defined as a
total SPPB score �9. To describe in detail which SPPB subtest was the most altered, we used
these following cutoffs: a score <4, except for walking speed (the cutoff < = 0.8m/s was used
[16]).
■ The unipodal balance test [17] consists of standing on one leg as long as possible (max 30
seconds), with open eyes. The test was repeated two times. The best performance from the 2
tests was used for the analyses. The unipodal balance test was considered as failed when the
patient could not stand this position for 30 seconds.
■ A “physical function impairment” variable was also described. A patient was considered
as having physical function impairment if at least more than one test (i.e. balance, gait speed,
5-STS or unipodal balance test) was altered, as defined above in the text for each test.
Self-reported measures. Additionally, daily physical function tasks were evaluated based
on self-reported difficulties in daily physical function such as climbing stairs, raising arm, car-
rying a 5kg grocery bag, walking a long distance, participating in community activities, and
visiting family. Each difficulty was evaluated with a Likert scale (no difficulty / mild / moderate
/ severe / extreme difficulties or cannot do).
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Grip strength
As SPPB assesses low extremity function and to have a complete description of muscular func-
tion in our PLHIV, the handgrip strength (kg) was measured to evaluate upper extremity max-
imal isometric muscle strength. The measure was realized in a standard way, twice
consecutively in the dominant hand using a calibrated Jamar hydraulic hand dynamometer.
The maximum value of the 2 trials was used for the analysis. For grip strength, as no normative
data obtained from a population with similar characteristics to ours were available, low grip
strength was defined as a performance less to the median obtained in each gender group
(male/female).
Measures of functional status
Activities of the daily living (ADL) [18] and Instrumental activities with daily living (IADL)
[19] scales were used to evaluate the autonomy of the patients. The ADL and IADL scores
range from 0 to 6 and 0 to 4, respectively (0 indicating the lowest degree of autonomy).
Other covariates
The practice of physical activity was evaluated with the WHO Global Physical Activity Ques-
tionnaire (GPAQ) [20], collecting information on physical activity in three situations: at work,
during moving from one place to another, and during hobbies. The last question evaluates phys-
ical inactivity (how many hours do you spend sitting or lying down during a day (without sleep-
ing). For the present study, we focused on global scores: physical inactivity (the patient did not
do physical activities at work or in leisure: yes/no) and intensity of physical activity (limited to
moderate vs high) which were calculated following the GPAQ analysis guide instructions.
Statistical analysis
The characteristics of the study sample were described with numbers and proportions as vari-
ables were presented in categorical variables. The median and interquartile range (IQR) for
describing the age and duration of the disease variables were also provided. For each physical
function tests, mean scores and standard deviation were provided. Grip strength was only
described according to gender.
For each test and the “physical function impairment” variable, the prevalence of low perfor-
mance was reported. As SPPB has been used for >20 years to measure physical performance
in older adults [15] and as it is a complete brief battery feasible to implement in HIV clinical
care [21], the further analyses focused on this test. Associations between low SPPB perfor-
mance and both other tests performance and daily physical activities were evaluated with Chi-
2 tests, except for grip strength for which the Student T-test was performed in each gender
group separately.
Factors associated with low SPPB performance were evaluated with univariable and multi-
variable logistic regression analyses. The multivariable logistic regression models included all
variables associated with the dependent variable with a p-value�0.2 in univariable analyses.
Unbalanced variables (85%/15%) were excluded from the analyses. The final model was
obtained with a backward selection, and we considered significant associations at p< 0.05.
“Inclusion centers” variable was included as a cofounder in each model. The goodness of fit of
the final model was evaluated with the Hosmer-Lemeshow test (p>0.05).
A multivariable imputation of missing data was performed with a Random Forest procedure.
No significant difference was observed between the two databases (with and without missing
data). The database with imputed missing data was used for the logistic regression analyses.
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Statistical analyses were computed using R software.
Results
Characteristics of the sample
A total of 333 patients were included in our study. The median (IQR) age was 57 (54–61) years
old. Among them, 35.1% were aged 60 years and older, 57.7% were female, and 50.7% had a
primary school or a lower level of education. Half of them lived alone (53.7%) and almost half
of them were unemployed (46.8%) (Table 1).
Among these patients, 53.1% had abdominal obesity and 37.8% were overweight or obese.
Less than a quarter ever had hypertension (21.9%) and/or tuberculosis (21.6%). Other comor-
bidities (diabetes, hyperlipidemia, migraine, and arthrosis) were less prevalent (6%, 3.6%,
10.2% and, 15.6%, respectively).
The majority of patients had an undetectable viral load (68.8%), half of them had CD4�500
(50.4%) and 60.9% had a Nadir CD4 <200. The median (IQR) duration of HIV infection was
108 months (68.9–141.4). Fourteen percent (14.4%) were on stage C at ART initiation. Con-
cerning ART, 68.2% had AZT, ddI, D4T, DDC included in their initial treatment whereas only
26.7% had those molecules in their current treatment.
Few patients reported substance use (hazardous drinkers or drug users <8%, except 17.7%
for tobacco users (current/previous)).
In terms of the ADL and IADL instruments, 96.4% and 99.1% of the patients obtained the
maximum score (6 or 4, respectively). Overall, 44.4% reported being physically inactive and,
among those reporting being active, 53.4% reported limited to moderate intensity in their
physical activity (data not shown).
Description of physical function, self-reported measures, and grip strength
The SPPB mean score was 10.2±1.8. Details in SPPB total and subscores are presented in sup-
plementary data (S1 and S2 Figs). The mean time to perform the 5STS was 12.5 ±3.5 seconds.
The mean walking speed was 1.3 ±0.3 meters per second.
Few patients reported moderate to extreme difficulties in daily physical function (<4%),
except for climbing stairs (14.1%) and carrying a grocery bag (8.4%) (S1 Table). Among
patients reporting those difficulties, few of them reported severe or extreme difficulties
(<2.5%). Only 5.4% of the patients reported at least one fall in the past year.
For women, the mean grip strength was 24.7 ±7.7 kg with 43.2% showing low grip strength
whereas, for men, the mean grip strength was 40.8 ±12.3 kg with 42.5% having low grip
strength.
Prevalence of physical function impairment
Almost one-third of the patients had low SPPB performance (28.8%; 95% Confident Interval
(CI): 24.0–33.6) (Table 2). Among the components of the SPPB, the 5STS was the most altered
test (64.2% [59.0–69.3] had a score of less than 4) whereas less than 27% had low performance
for balance or walking speed. Concerning unipodal balance, 38.6% had low performance.
Overall, 45.6% [40.2–50.9] of the patients had physical function impairment.
Associations between SPPB performance and other tests
A significant association between SPPB score and unipodal test performance was observed
(χ2 = 10.7, p = 0.001). Of 96 PLHIV with low SPPB performance, 54.2% had low performance
on unipodal test. Concerning grip strength, men with low SPPB performance had significantly
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Table 1. Characteristics of the study sample (N = 333).









In couple 154 46.2
Alone 179 53.7
Level of education
Primary or less 169 50.7
Secondary or more 164 49.2
Professional activity
Employed 177 53.1
Not employed 156 46.8
Anthropometric and medical data
Abdominal obesity (mis. 1) 177 53.1
Overweight/obesity (mis. 1) 126 37.8
Hypertension (mis. 1) 73 21.9
History of tuberculosis 72 21.6
Arthrosis (mis. 1) 52 15.6
History of neurological disease 47 14.1
Migraine 34 10.2
History of trauma (mis. 2) 22 6.6
Diabetes 20 6.0
Other medical problem (mis. 3) 14 4.2
Hyperlipidemia (mis. 2) 12 3.6
B or C hepatitis (mis. 1) 9 2.7
HIV Clinical data
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lower mean grip strength than men with high SPPB performance (35.7±9.1 kg vs 41.9±12.7,
T = 2.94, p = 0.005). No significant difference was observed between both women’s groups
(T = 0.94, p = 0.93).
SPPB performance and daily physical activities
A significant association was observed between low SPPB performance and physical inactivity
(57.3%, χ2 = 8.3, p = 0.004). Low SPPB performance was also associated with limited to mod-
erate intense activities (61.5%, χ2 = 11.2, p = 0.001). Concerning daily physical activities, low
Table 1. (Continued)
Characteristics Number Percentages (%)
Detectable Viral load 48 14.4
Missing 56 16.8
Initial treatment including AZT, ddI, D4T, DDC† 227 68.2
Current treatment including AZT, ddI, D4T, DDC 85 25.5
Poor Adherence 19 5.7
Substance use
Hazardous drinkers 24 7.2
Tobacco use (current/former) 59 17.7
Drug consumption (mis. 1) 6 1.8
Physical function Mean performance ± SD �
SPPB (score) 10.2 ±1.8
5STS (time–seconds) 12.5 ±3.5
Walking speed (m/s) 1.3 ±0.3
Activities of daily living (score = 6) 321 96.4
Instrumental Activities of daily living (score = 4) 330 99.1
Physical inactivity 148 44.4
Abbreviations: ART: Antiretroviral, AZT: Zidovudine, ddI: Didanosine, DDC: Zalcitabine, D4T: Stavudine, mis.:
Missing, m/s: Meter per second, SPPB: Short Physical Performance Battery, 5STS: Five Sit-To-Stand, SD: Standard
deviation.
�Unipodal test results are presented in Table 2 only (categorical variable).
† Others drugs included in ART could be: 3TC: Lamivudine, ABC: Abacavir, ATV: Atazanavir, DRV: Darunavir,
EFV: Efavirenz, FTC: Emtricitabine, LPV: Lopinavir, NVP: Névirapine, RTV: Ritonavir or TDF: Ténofovir.
https://doi.org/10.1371/journal.pone.0240906.t001
Table 2. Prevalence of physical function impairment for each test.
Tests Prevalence (%) [95%CI]��
SPPB (score�9) 28.8 [24.0–33.7]
SPPB subtests
5STS (score<4) 64.2 [59.0–69.3]
Walking speed (speed < = 0.8m/s) 27.0 [22.2–31.8]
Balance (score <4) 16.2 [12.2–20.2]
Unipodal balance (Vereeck et al, 2008) 38.6 [33.4–43.8]
Physical function impairment 45.6 [40.2–50.9]
Abbreviations: CI: Confident Interval, SPPB: Short Physical Performance Battery, 5STS: Five Sit-to-Stand, m/s:
meter per second.
�� The prevalence data is for the patients who scored below the cut off values.
https://doi.org/10.1371/journal.pone.0240906.t002
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SPPB performance was also associated with difficulties in climbing stairs (45.8%, χ2 = 13.7)
and walking one block (22.1%, χ2 = 14.6) (p<0.0001 for both).
Factors associated with low SPPB performance
In univariable models (Table 3), age�60 years (OR = 2.7; CI95% = 1.6–4.5), being a female
(OR = 2.2; CI95% = 1.3–3.7), single (OR = 1.8; CI95% = 1.1–3.0) and unemployed (OR = 2.4;
CI95% = 1.4–3.9) were associated with low SPPB performance. Patients with abdominal obe-
sity (OR = 2.4; CI95% = 1.5–4.1), hypertension (OR = 2.2; CI95% = 1.2–3.8), diabetes
(OR = 3.1; CI95% = 1.2–8.0), a longer duration of HIV infection (OR = 2.7; CI95% = 1.5–5.2),
those who had AZT, DDI, D4T or DDC in their initial ART (OR = 1.9; CI95% = 1.1–3.4) and
in their current ART (OR = 1.9; CI95% = 1.1–3.2) also had low SPPB performance.
In the multivariable model (Table 3), age 60 years and above (adjusted OR (aOR) = 3.4;
CI95% = 1.9–5.9), being a female (aOR = 2.1; CI95% = 1.1–4.1), having an abdominal obesity
(aOR = 2.1; CI95% = 1.2–4.0), a longer duration of HIV infection (aOR = 2.9; CI95% = 1.5–
5.7) and AZT, DDI, D4T or DDC in their current ART (aOR = 2.0; CI95% = 1.1–3.7)
remained associated with low SPPB performance.
Discussion
In the present study, in a large sample of PLHIV aged 50 years old and above, physical func-
tion limitation evaluated with the SPPB is observed in almost 30% of the patients. The 5STS
seems to be the most altered sub-test in the SPPB. PLHIV with low SPPB performance also
had low unipodal balance performance, and low mean grip strength (in men only). Low
SPPB performance is mainly associated with being aged above 60, but also being female,
having abdominal obesity, and longer duration of the disease. The use of old Nucleoside
reverse transcriptase inhibitors (NRTIs) in the current ART is also associated with lower
performance.
Recent publications in older PLHIV from western countries reported similar results for the
SPPB performance. In PLHIV aged 50 years or above living in the United States, it was
reported a similar mean score (10.3 to 10.7) [21,22], a score similar to nearly 20-year older con-
trols [21]. Another study in female PLHIV reported that 20% of them performed poorly with a
median score of 11, but they discussed the possibility of a ceiling effect because of the partici-
pant’s age in their sample (i.e. median age: 49 years (range 40–66 years)) [23]. In a cohort of
drug users (median age: 51 years old), HIV infection was also associated with a 30% higher
risk of reduced physical performance [24]. Functional impairment is associated with low bone
and muscle mass among persons aging with HIV-infection [25]. In PLHIV but also in the gen-
eral population, low SPPB performance has already been associated with poorer outcomes
such as having additional comorbidities, subsequent disability, falls, higher mortality, and hos-
pitalization rates [15,21,24,26–29], highlighting the importance of the screening of this
impairment.
The most altered component of the SPPB test was the 5STS as observed in middle-aged
PLHIV in western countries [9,10] and in older PLHIV [21,22]. PLHIV needed more time to
complete the test than controls [22] but less than the nearly 20-year older controls [21]. As rec-
ommended in an editorial in AIDS [30], the 5STS might be the most appropriate test to evalu-
ate physical function in the standard care of PLHIV. Our results also showed that this test was
the most altered, but the absence of normative data adapted to our population was a limit to go
further in our investigation. The results presented here are the baseline data of a 2-year longi-
tudinal study. Data collected during the follow-up will enable us to investigate the evolution of
the 5STS and to describe the factors which best predict this decline.
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Table 3. Analysis of factors associated with low SPPB performance in the study population.
Variables Univariable model Multivariable model
OR (CI 95%) p-value aOR (CI 95%) p-value
Age <0.0001�
50–59 years old 1
�60 years old 2.7 (1.6–4.5) 3.4 (1.9–5.9) <0.0001�
Gender 0.004�
Men 1




Level of education 0.280
Primary or less 1









Yes 2.4 (1.5–4.1) 2.1 (1.2–4.0) 0.014�
Hypertension (ref.: no)† 2.2 (1.2–3.8) 0.006�
Hyperlipidemia (ref.: no) 1.9 (0.6–6.6) 0.265
Diabetes (ref.: no) 3.1 (1.2–8.0) 0.020�
B or C hepatitis (ref.: no) 0.6 (0.1–2.9) 0.585
Tuberculosis (ref.: no) 1.3 (0.7–2.3) 0.420
Migraine (ref.: no) 0.7 (0.3–1.7) 0.477
Arthrosis (ref.: no) 1.6 (0.8–3.1) 0.165
Other medical problem (ref.: no) 1.6 (0.5–5.0) 0.411
History of trauma (ref.: no) 0.4 (0.1–1.1) 0.115
History of neurological disease (ref.: no) 1.6 (0.8–3.2) 0.193
Duration of HIV infection (months)
[7.29,88.4] 1
(88.4,131] 1.8 (0.9–3.4) 0.071 1.5 (0.8–3.0) 0.238
(131,317] 2.7 (1.5–5.2) 0.002� 2.9 (1.5–5.7) 0.002�
Clinical disease stages
A 1
B 1.0 (0.6–1.8) 0.997
C 0.8 (0.3–1.7) 0.547
Nadir CD4 (cells/μl)
<200 1
� 200 1.3 (0.7–2.1) 0.366
Abbreviations: aOR: Adjusted Odds Ratio, ART: Antiretroviral therapy, BMI: Body Mass Index, CI: Confidence Interval, DDC: Zalcitabine, ddI: Didanosine, D4T:
Stavudine, SPPB: Short Physical Performance Battery, OR: Odd ratio, RAL: Raltégravir, AZT: Zidovudine.
�results considered as significant (p<0.05).
†ref: no: means that the OR is computed taking this category “absence of this medical problem” as a reference.
https://doi.org/10.1371/journal.pone.0240906.t003
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Low SPPB performance has been associated with older age. The impact of aging on physical
function is well-known and linked to age-related losses in skeletal muscle mass and low aerobic
capacity [31,32]. Other studies from western and African countries reported an effect of age on
physical function [9–11]. We also observed that PLHIV with abdominal obesity had low physi-
cal performance whereas no association was observed with BMI. The impact of nutrition and
nutritional status on physical function limitation has already been observed [9,11]. People with
excessive body mass may have more limited endurance-based performance [33] and also have
increased cardiovascular risks. Finally, as shown by Richert et al [9], we observed that PLHIV
with longer duration of the disease were more likely to have a low physical function whereas
no significant association was observed with other HIV outcomes (CD4 or viral load). The
long-term effect of the virus, inflammatory process, and direct or indirect effects of ART treat-
ment could explain this association but further investigations need to be conducted. We also
observed the effect of old NRTIs included in ART, such as Zidovudine, known as having myo-
toxic consequences. Further studies with a more detailed protocol evaluating the duration of
exposition to those molecules could help to understand better the phenomenon.
Concerning grip strength, in accordance with other studies in PLHIV or African popula-
tions [21,34–36], the mean performance was lower in women than the men ones. In a recent
US study in older PLHIV, similar grip strength as in our cohort was observed in women and
men (26.5 kg and 38.2 kg respectively) [21]. Weaker grip strength has also been reported in
African PLHIV in comparison to HIV-uninfected subjects [37,38]. Even if men’s grip strength
was associated with low SPPB performance in our study, this was not the case for women.
Because of the absence of normative data developed in SSA, we decided not to go any further
in the interpretation of the data. As low grip strength is associated with bad outcomes (ie mor-
tality, longer hospitalization, and physical function limitation) [39], it is important to stan-
dardize procedure [40] and to have regional specific data [41]. One study in Nigeria reported
normative data for adults aged between 20 to 69 years old but with a small proportion of sub-
jects aged�50 years old [34].
To our knowledge, this study represents the first opportunity to describe physical function
in a large sample of older PLHIV in West Africa. However, some limitations have to be men-
tioned. First, we observed that the PLHIV included in the study reported few difficulties activi-
ties of daily living. The ADL and IADL are two scales usually used to evaluate the autonomy
and the independence of older subjects (�65 years old). Moreover, the questions in these scales
might not be completely adapted to the West African population. Adapted scales have recently
been published and might be more adapted to the African context [42]. Second, the generaliz-
ability of our results could be limited since we have included PLHIV from urban sites, under
ART for at least 6 months, without important difficulties in activities of daily living and major
neurologic complications or addictive behaviors. We may have selected the most adherent
PLHIV and the most engaged in medical care. However, even in this population, poor physical
functioning still occurs and should not be neglected. Interestingly, this population presented
some specific characteristics and more specifically, more women than men were included and
the majority did not report any substance use. Those characteristics could influence the gener-
alizability of our results but also the comparison with other studies. Third, although we did not
have a comparison group of HIV-negative adults included in the present study, we were able to
compare our results to the prevalence of low SPPB performance reported in other papers.
Fourth, the absence of normative data in grip strength adapted to our population was also a
limit to go any further in some aspects of our investigation. Further studies are needed to depict
this as it is an important point both for research and clinical domains. Fifth, even imputation
for missing data was performed, the “viral load” variable presented some missing data, thus lim-
iting the exploration of the association with SPPB performance.
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Conclusions
Hence, despite a successful ART, the prevalence of physical function limitation in older
PLHIV is high, and this burden impacts some daily activities. Longitudinal studies should be
performed to assess the evolution of the physical function limitation, their predictors, and to
evaluate in more detail their consequences on daily activities. The impact of bone density, not
evaluated in this study, should also be assessed. Then, how to integrate the measurement and
the management of physical function limitation in the standard of care should be investigated.
As the 5STS was the most altered test, it could be interesting to perform it in standard care as
recommended in western countries. Efforts are now needed to develop normative data in SSA
populations. Finally, age and abdominal obesity were main factors associated with low physical
performance. Practitioners need to promote the practice of physical activity and to educate
their patients about a better diet to limit the occurrence of overweight and obesity, and so to
prevent disability in older PLHIV. Further studies are needed to develop adapted interventions
focusing on a daily physical activity program, that might limit the deterioration in physical
performance and the bad consequences on daily life in this population.
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Takassi, CHU Sylvanus Olympio, Lomé,Togo; Coordinators and data centers: François Dabis,
Elise Arrive, Eric Balestre, Renaud Becquet, Charlotte Bernard, Shino Chassagne Arikawa,
Alexandra Doring, Antoine Jaquet, Karen Malateste, Elodie Rabourdin, Thierry Tiendrebeogo,
ADERA, Isped & INSERM U1219, Bordeaux, France. Sophie Desmonde, Julie Jesson, Valer-
iane Leroy, Inserm 1027, Toulouse, France. Didier Koumavi Ekouevi, Jean-Claude Azani, Pat-
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Resources: Zélica Diallo, Richard Ahonon, Judicaël Malick Tine, Franklin Abouo, Aristoph-
ane Tanon, Eugène Messou, Moussa Seydi.
Software: Hélène Font.
Supervision: Charlotte Bernard, Aristophane Tanon, Eugène Messou, Moussa Seydi, François
Dabis, Nathalie de Rekeneire.
Validation: Charlotte Bernard, Hélène Font, Nathalie de Rekeneire.
Visualization: Charlotte Bernard.
Writing – original draft: Charlotte Bernard.
Writing – review & editing: Charlotte Bernard, Hélène Font, Zélica Diallo, Richard Ahonon,
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